TrialJAMA2021

Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

Franco Locatelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.